Kiniksa Pharmaceuticals, Ltd. (KNSA)
Largest Insider Buys in Sector
KNSA Stock Price History Chart
KNSA Stock Performance
About Kiniksa Pharmaceuticals, Ltd.
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda.
Insider Activity of Kiniksa Pharmaceuticals, Ltd.
Over the last 12 months, insiders at Kiniksa Pharmaceuticals, Ltd. have bought $0 and sold $4.53M worth of Kiniksa Pharmaceuticals, Ltd. stock.
On average, over the past 5 years, insiders at Kiniksa Pharmaceuticals, Ltd. have bought $0 and sold $6.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 6,000,000 shares for transaction amount of $108M was made by BAKER BROS. ADVISORS LP () on 2018‑05‑29.
List of Insider Buy and Sell Transactions, Kiniksa Pharmaceuticals, Ltd.
| 2024-03-07 | Sale | Patel Sanj K | CHAIRMAN & CEO | 65,012 0.0919% | $21.02 | $1.37M | -9.69% | |
| 2024-03-06 | Sale | Patel Sanj K | CHAIRMAN & CEO | 5,582 0.008% | $21.00 | $117,222 | -8.44% | |
| 2024-03-04 | Sale | Patel Sanj K | CHAIRMAN & CEO | 12,742 0.0194% | $21.49 | $273,834 | -4.71% | |
| 2024-03-01 | Sale | Tessari Eben | CHIEF OPERATING OFFICER | 1,189 0.0017% | $22.03 | $26,194 | -11.41% | |
| 2024-03-01 | Sale | Paolini John F. | CHIEF MEDICAL OFFICER | 18,844 0.0269% | $21.77 | $410,234 | -11.41% | |
| 2024-03-01 | Sale | Megna Michael R | CHIEF ACCOUNTING OFFICER | 9,659 0.0136% | $21.45 | $207,186 | -11.41% | |
| 2024-02-28 | Sale | Megna Michael R | CHIEF ACCOUNTING OFFICER | 5,126 0.0078% | $21.79 | $111,696 | -5.06% | |
| 2024-02-27 | Sale | Paolini John F. | CHIEF MEDICAL OFFICER | 10,156 0.0145% | $21.03 | $213,581 | -7.35% | |
| 2024-01-03 | Sale | Ragosa Mark | CHIEF FINANCIAL OFFICER | 12,000 0.0171% | $20.00 | $240,000 | -5.03% | |
| 2024-01-02 | Sale | Megna Michael R | CHIEF ACCOUNTING OFFICER | 16,670 0.0245% | $19.17 | $319,564 | +3.18% | |
| 2023-12-19 | Sale | Megna Michael R | CHIEF ACCOUNTING OFFICER | 9,316 0.0133% | $19.13 | $178,215 | -0.01% | |
| 2023-12-07 | Sale | Paolini John F. | CHIEF MEDICAL OFFICER | 28,600 0.0801% | $17.65 | $504,758 | +7.23% | |
| 2023-09-05 | Sale | Paolini John F. | CHIEF MEDICAL OFFICER | 400 0.0006% | $17.53 | $7,012 | +8.08% | |
| 2023-07-25 | Sale | Paolini John F. | CHIEF MEDICAL OFFICER | 29,000 0.0409% | $19.14 | $555,160 | -7.39% | |
| 2022-11-29 | Sale | Quart Barry D | director | 21,959 0.0318% | $16.15 | $354,638 | -6.53% | |
| 2022-11-07 | Sale | Paolini John F. | CHIEF MEDICAL OFFICER | 56,714 0.0814% | $15.18 | $860,919 | -1.54% | |
| 2021-02-10 | Sale | Patel Sanj K | Chairman & CEO | 5,474 0.0085% | $23.06 | $126,253 | -38.71% | |
| 2021-02-09 | Sale | Patel Sanj K | Chairman & CEO | 87,940 0.1324% | $23.06 | $2.03M | -40.33% | |
| 2021-02-08 | Sale | Patel Sanj K | Chairman & CEO | 18,904 0.0209% | $17.42 | $329,369 | -41.64% | |
| 2021-02-03 | Sale | Beetham Thomas W. | EVP & Chief Legal Officer | 4,954 0.0076% | $22.09 | $109,434 | -36.09% |
Insider Historical Profitability
| Tessari Eben | CHIEF OPERATING OFFICER | 122847 0.1753% | $18.53 | 0 | 1 | |
| Paolini John F. | CHIEF MEDICAL OFFICER | 44892 0.0638% | $18.53 | 0 | 10 | |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | 17588 0.0242% | $18.53 | 0 | 4 | |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | 15632 0.0222% | $18.53 | 0 | 1 | |
| Patel Sanj K | Chairman & CEO | 0 0% | $18.53 | 1 | 9 | |
| BAKER BROS. ADVISORS LP | 2700597 3.8394% | $18.53 | 2 | 0 | +4.3% | |
| Cormorant Asset Management, LP | director | 900443 1.2802% | $18.53 | 1 | 0 | +4.3% |
| Flynn James E | 10 percent owner | 843352 1.199% | $18.53 | 1 | 0 | +4.3% |
| Beetham Thomas W. | EVP & Chief Legal Officer | 297523 0.423% | $18.53 | 1 | 6 | |
| BOESS CARSTEN | 10 percent owner | 6392 0.0091% | $18.53 | 1 | 0 | |
| Heberlig Chris | Exec VP & CFO | 6392 0.0091% | $18.53 | 1 | 0 | |
| Mahoney Stephen F. | President & COO | 6392 0.0091% | $18.53 | 1 | 0 | |
| Quart Barry D | director | 0 0% | $18.53 | 0 | 1 |
Institutional Investor Ownership
| BlackRock | $82.75M | 5.91 | 4.19M | +31.86% | +$19.99M | <0.01 | |
| Fairmount Funds Management LLC | $63.23M | 4.52 | 3.2M | +11.15% | +$6.35M | 6.89 | |
| Hillhouse Capital Advisors Ltd | $61.87M | 4.42 | 3.14M | New | +$61.87M | 1.35 | |
| The Vanguard Group | $58.83M | 4.2 | 2.98M | +0.56% | +$327,419.35 | <0.01 | |
| Baker Bros Advisors LP | $55.43M | 3.96 | 2.81M | 0% | +$0 | 0.7 | |
| Helm Capital Management LLC | $43.33M | 3.1 | 2.2M | -24.47% | -$14.04M | 1.28 | |
| State Street | $37.26M | 2.66 | 1.89M | +22.15% | +$6.76M | <0.01 | |
| Braidwell Lp | $27.48M | 1.96 | 1.39M | New | +$27.48M | 1.55 | |
| Morgan Stanley | $25.07M | 1.79 | 1.27M | -20.36% | -$6.41M | <0.01 | |
| Nuveen | $16.4M | 1.17 | 831,099 | +102.2% | +$8.29M | 0.01 | |
| Goldman Sachs | $15M | 1.07 | 760,107 | -16.4% | -$2.94M | <0.01 | |
| Geode Capital Management | $14.32M | 1.02 | 725,511 | +3.7% | +$511,037.18 | <0.01 | |
| Arrowmark Colorado Holdings Llc | $13.16M | 0.94 | 666,976 | -6.7% | -$945,126.16 | 0.03 | |
| Granahan Investment Management | $12.79M | 0.91 | 648,087 | -10.29% | -$1.47M | 0.45 | |
| Parkman Healthcare Partners Llc | $12.75M | 0.91 | 646,163 | +4.95% | +$601,173.10 | 1.57 | |
| Driehaus Capital Management LLC | $12.28M | 0.88 | 622,540 | -5.92% | -$772,922.74 | 0.12 | |
| Rice Hall James & Associates, LLC | $12.21M | 0.87 | 618,798 | -2.71% | -$339,967.64 | 0.74 | |
| Dimensional Fund Advisors | $9.99M | 0.71 | 506,299 | +44.76% | +$3.09M | <0.01 | |
| Tang Capital Management, LLC | $9.87M | 0.71 | 500,000 | -16.67% | -$1.97M | 0.04 | |
| Northern Trust | $5.73M | 0.41 | 290,644 | -3.16% | -$187,040.43 | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $5.16M | 0.37 | 261,698 | +0.93% | +$47,647.95 | 0.01 | |
| Millennium Management LLC | $4.72M | 0.34 | 239,409 | -44.11% | -$3.73M | <0.01 | |
| PEREGRINE CAPITAL MANAGEMENT INC | $4.66M | 0.33 | 236,045 | New | +$4.66M | 0.14 | |
| D. E. Shaw & Co. | $4.38M | 0.31 | 221,853 | -27.17% | -$1.63M | 0.01 | |
| Schonfeld Group | $4.28M | 0.31 | 216,908 | -4.21% | -$188,283.35 | 0.03 | |
| Bank of America | $4.19M | 0.3 | 212,505 | +320.44% | +$3.2M | <0.0001 | |
| Citigroup | $3.77M | 0.27 | 191,020 | +312.05% | +$2.85M | <0.01 | |
| Arrowstreet Capital, Limited Partnership | $3.67M | 0.26 | 185,813 | +142.09% | +$2.15M | <0.01 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3.41M | 0.24 | 172,740 | +0.49% | +$16,770.50 | 0.68 | |
| Acadian Asset Management | $3.24M | 0.23 | 164,568 | +167.82% | +$2.03M | 0.01 | |
| Knights of Columbus Asset Advisors LLC | $3.2M | 0.23 | 162,283 | New | +$3.2M | 0.24 | |
| AQR Capital | $3.14M | 0.23 | 159,323 | -30.14% | -$1.36M | 0.01 | |
| Hussman Strategic Advisors Inc | $3.11M | 0.22 | 157,500 | New | +$3.11M | 0.72 | |
| Prudential Financial | $3.08M | 0.22 | 156,210 | -8.12% | -$272,273.97 | <0.01 | |
| Hudson Bay Capital Management LP | $2.98M | 0.21 | 151,000 | -29.77% | -$1.26M | 0.03 | |
| Rafferty Asset Management Llc | $2.78M | 0.2 | 140,863 | +46.95% | +$888,007.84 | 0.01 | |
| Los Angeles Capital Management LLC | $2.76M | 0.2 | 139,850 | -4.98% | -$144,660.39 | 0.01 | |
| State of Wisconsin Investment Board | $2.72M | 0.19 | 137,647 | +69.77% | +$1.12M | 0.01 | |
| Susquehanna International Group | $2.59M | 0.19 | 131,223 | +265.6% | +$1.88M | <0.01 | |
| Lion Point Capital LP | $2.58M | 0.18 | 130,691 | 0% | +$0 | 5 | |
| Qube Research & Technologies | $2.54M | 0.18 | 128,821 | +36.32% | +$677,172.97 | <0.01 | |
| Nordea Investment Management Ab | $2.49M | 0.18 | 126,742 | New | +$2.49M | <0.01 | |
| Ameriprise Financial | $2.31M | 0.17 | 117,231 | -29.07% | -$948,105.16 | <0.01 | |
| Linden Thomas Advisory Services Llc | $2.3M | 0.16 | 116,381 | +1.6% | +$36,125.63 | 0.37 | |
| BNY Mellon | $2.22M | 0.16 | 112,580 | -15.7% | -$413,797.40 | <0.0001 | |
| UBS | $2.07M | 0.15 | 104,762 | +22.65% | +$381,696.53 | <0.01 | |
| Citadel Advisors LLC | $2.08M | 0.15 | 105,290 | -50.96% | -$2.16M | <0.01 | |
| Cubist Systematic Strategies | $2.03M | 0.15 | 102,997 | +186.77% | +$1.32M | 0.02 | |
| Ubs Oconnor Llc | $1.86M | 0.13 | 94,495 | -6.18% | -$122,858.69 | 0.16 | |
| Deutsche Bank | $1.81M | 0.13 | 91,744 | +0.42% | +$7,596.05 | <0.01 |